NOVEL PYRIMIDINE DERIVATIVES WITH ANTICONVULSANT AND PSYCHOTROPIC EFFECTS
https://doi.org/10.17749/2077-8333.2017.9.3.040-046
Abstract
Objective: to study the anticonvulsant and psychotropic effects of novel benzothienopyrimidine derivatives and rationalize their use for medical practice.
Materials and methods. The anticonvulsant effects were studied by using the models of murine seizure induced with corazole, camphor, thiosemicarbazide, picrotoxin, or strychnine as well as the maximal electroshock. The psychotropic properties of the compounds were studied using the “open field”, “elevated crossshaped maze”, “forced swimming”, “electroshock retrograde amnesia”, or “rotating rod” models in mice and rats.
Results. The benzothienopyrimidine derivatives showed high anticonvulsant activities, especially against the corazoleinduced seizures.
Conclusion. The tested compounds surpass the well-known clinically used anticonvulsants 3-(p-Isopropoxyphenyl)succinimide and ethosuximide. One of the tested compounds is selected and recommended for further development as an anticonvulsant with psychotropic properties.
About the Author
R. G. Paronikyan
The Institute of fine organic chemistry named after A. L. Mnjoyan scientific-technological center of organic and pharmaceutical chemistry of NAS of Republic of Armenia
Armenia
Armenia
PhD, Associate Professor, Senior researcher, Institute of fine organic chemistry named after A. L. Mnjoyan, Scientific technological center of organic and pharmaceutical chemistry of NAS of the Republic of Armenia. Address: pr. Azatutyan, 26, Erevan, Armeniya, 0014
References
1. Vogel H. G., Vogel W. H. Psychotropic and neurotropic activity. In: Drug Discovery and Evaluation: Pharmacological Assays.Ed. H. E. Vogel. Springer. Berlin and N.Y. 2008; 569-874.
2. Robert M. A. Hirschfeld: Guideline Watch: Practice Guideline for the Treatment of Patients With Bipolar Disorder, 2nd Edition, in American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders 2004. 2011; 82.
3. Shnute M. E., Brideau R. J., Collier S. A., Cudahy M. M., Hopkins T. A., Knechtel M. L, Oien N. L, Sackett R. S., Scott A., Stephan M. L., Wathen, M. W., Wriefer J. Med. Chem Lett. 2008; 18: 3856-3859.
4. Gineinah M. M., Nasr M. N. A., Badr S. M. I., El-Husseiny W. M. Med. Chem. Res. 2013; 22: 3943-3942.
5. Jiang N., Deng X. K., Li F. N., Quan Z. Sh., Iranian J. Pharm. Res. 2012; 11: 799-806.
6. Baraladi P. G., Cacciari B., Moro S., Spalluto G., Pastorin G., Da Ros T., Klotz K. N., Varani K., Gessi S., Borea P. A. J. Med. Chem. 2002; 45: 770-780.
7. Paronikyan E. G., Noravyan A. S., Akopyan A. Sh., Dzhagatspanyan I. A., Nazaryan I. M., Paronikyan R. G. Khimikofarmatsevticheskii zhurnal (in Russian). 2007; 41 (9): 14-16.
8. Paronikyan E. G., Akopyan A. Sh., Noravyan A. S., Dzhagatspanyan I. A., Nazaryan I. M., Akopyan A. G. Khimikofarmatsevticheskii zhurnal (in Russian). 2010; 44 (4): 19-21.
9. Guidelines for the content and use of laboratory animals. The eighth edition (translated from English, edited by IV Belozertzova, DV Blinov, MS Krasil’shchikova [Rukovodstvo po soderzhaniyu i ispol’zovaniyu laboratornykh zhivotnykh. Vos’moe izdanie (per. s angl. pod red. I. V. Belozertsovoi, D. V. Blinova, M. S. Krasil’shchikovoi (in Russian)]. Moscow: IRBIS. 2017; 336 s.
10. Dzhagatspanyan I. A, Paronikyan R. G., Nazaryan I. M., Akopyan A G. Meditsinskaya nauka v Armenii. 2006; 4: 14-19.
11. Behavioral and Cognitive Effecte of anticonvulsant Therapy (RE 9537). Polrey statement. 1995; 96 (3): 538-540.
12. Boldyrev A. I. Zhurnal nevrologii i psikhiatrii (in Russian). 1998; 7: 9-11.
13. Pelow S., File S. E. Pharmacol. Biochem. and Behav. 1986; 24 (3): 525-529.
14. Porsolt R. D. et al. Eur. J. Pharmacol. 1978; 47: 379-391.
15. Martindal: The Complete Drug Reference. 36 edition, 2009. N.Y.: The Pharmaceutical Press. 3694 p.
16. Buresh J., Bureshova O. J. compphisiol. psychol. 1963; 756: 286-272.
17. Covanis A., Gupta A., Jeavons P. Epilepsia. 1982; 23: 693-720.
18. Dunham N. W., Miya T. S. A note on a simple apparatus for detecting neurological eficitin rats and mice. J. Am. Pharm. Ass. Sci. Ed. 1957; 46 (3): 208-209.
19. Belen’kii M. L. Quantitative assessment of the pharmacological effect [Kolichestvennaya otsenka farmakologicheskogo effekta (in Russian)]. Moscow. 1961; 152 s.
Review
For citations:
Paronikyan R.G. NOVEL PYRIMIDINE DERIVATIVES WITH ANTICONVULSANT AND PSYCHOTROPIC EFFECTS. Epilepsy and paroxysmal conditions. 2017;9(3):39-46. (In Russ.) https://doi.org/10.17749/2077-8333.2017.9.3.040-046
Views: 682
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
